SchaferAutismReport: New Autism Drug Offers Hope

[Guest guest]

From: sarnets-bounces@...

On Behalf Of Schafer Autism

Report

Sent: Thursday, September 16, 2010 9:30 PM

To: Schafer Autism Report

Subject: New Autism Drug Offers Hope

Read

this report online

Large text, printer version

Thursday, September 16, 2010p

Reader Supported

AUTISM

CALENDAR DEADLINE

September 24 !

For October 2010

Submit listing here

free!

RESEARCH

New Autism Drug Offers Hope

By Jyoti Pal xrl.in/6cxy

In a remarkable medical

breakthrough, researchers at the Indiana University School of Medicine have

developed a drug that helps alleviate Autism symptoms.

The drug, Arbaclofen, designed to rebalance

brain chemistry hailed as the first treatment that could help ease Autism’s

distressing symptoms

Details of the study For the purpose of the

study, Craig kson from the Indiana University School of Medicine and team

enrolled 25 Autistic children aged between 6 and 17.

The severity of the condition, detailing

levels of communication, imagination, and social relationships problems were

tracked for each patient.

The drug was administered to each participant

for over eight weeks.

At the end of eight-week clinical trail, the

participants were calmer and more sociable. They made eye contact more

frequently, were less anxious, and become less irritable than at the start,

researchers found.

" We observed marked improvement in the

majority of patients treated in the study, including reductions in agitation

and tantrums. They made eye contact more easily and were less anxious than at

the start,†said kson.

“This work will potentially open up a door in

treating disorders that has, until recently, been firmly shut, " kson

averred.

How does Arbaclofen work? Autism is a

developmental disorder of the brain typically characterized by impaired

social interaction and communication,and restricted and repetitive behavior.

The current line of treatment typically

includes use of anti-depressants and anti-psychotics that target only

specific symptoms.

Arbaclofen, the new autism drug being

developed by Seaside Therapeutics in Cambridge, Massachusetts, works by

rebalancing the brain chemistry.

" We are trying to normalize signaling

functions

For rest of today's

SAR click here:

www.sarnet.org/frm/forsar.htm

Today's

SAR newslist

is human compiled and provided through the support of

paid subscriptions.

- THANK YOU -

$35 for 1 year - or free!

www.sarnet.org

In This Issue:

•

•

•

•

•

•

•

•

•

•

RESEARCH

New Autism Drug Offers Hope

Research Sheds Light On Why Autism Is More Prevalent In Boys

Autistic Children Don't Seem to Yawn 'Contagiously'

PEOPLE

Autism’s First Child

Couple Accused In Autistic Son Scam Plead Not Guilty

SF Man Pleads Guilty To Pelosi Harassment

EDUCATION

Suit Over Shock Therapy By Mass. School Settled

RESOURCES

How To Protect Children With Autism From Bullying

PUBLIC HEALTH

Toddler Vaccination Rate Remains High Better than 90 percent, says CDC

COMMENTARY

Prenatal and Infant Exposure to Thimerosal From Vaccines and

Immunoglobulins and Risk of Autism

DO SOMETHING ABOUT AUTISM NOW

.. . . Read, then Forward

the Schafer Autism Report.

$35 for 1 year - or free!

www.sarnet.org

Hundreds of Local

Autism Events

Web / Everywhere

Alabama

Alaska

Arizona

Arkansas

California

Colorado

Connecticut

Delaware

District of Columbia

Florida

Georgia

Hawaii

Idaho

Web / Everywhere

Illinois

Indiana

Iowa

Kansas

Kentucky

Louisiana

Maine

land

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Web / Everywhere

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Web / Everywhere

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

Utah

Vermont

Virginia

Washington

West Virginia

Wisconsin

Wyoming

Web / Everywhere

Send

your LETTER

Now's the perfect time to order your free Puzzle Piece kits and launch an

autism awareness campaign in your community. When we raise the funding

necessary, ARI will see that important research is done, including the

large-scale, independent study of vaccinated vs. unvaccinated children Click here.

SAR Back Issues

The

Autism Community

Supports the

Schafer Autism Report

.. . . Read, then Forward

the Schafer Autism Report.

$35 for 1 year - or free!

www.sarnet.org

Biomedical Treatments for Autism Spectrum Disorders

Scientific References and Abstracts

www.autismbiomed.com

Copyright Notice: The above items are copyright protected. They

are for our readers' personal education or research purposes only and

provided at their request. Articles may not be further reprinted or used

commercially without consent from the copyright holders. To find the

copyright holders, follow the referenced website link provided at the

beginning of each

item.

Lenny Schafer editor@...

The Schafer Autism Report is

a non-profit corporation

Vol. 14 No. 88

Unsubscribe here: www.sarnet.org/frm/unsub2.htm

1 of 1 File(s)

ATT00024.txt